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Hyperspectral imaging (HSI) is a non-invasive optical imaging modality that shows the
potential to aid pathologists in breast cancer diagnoses cases. In this study, breast cancer
tissues from different patients were imaged by a hyperspectral system to detect spectral
differences between normal and breast cancer tissues. Tissue samples mounted on
slides were identified from 10 different patients. Samples from each patient included
both normal and ductal carcinoma tissue, both stained with hematoxylin and eosin
stain and unstained. Slides were imaged using a snapshot HSI system, and the spectral reflectance differences were evaluated. Analysis of the spectral reflectance values
indicated that wavelengths near 550 nm showed the best differentiation between tissue
types. This information was used to train image processing algorithms using supervised
and unsupervised data. The K-means method was applied to the hyperspectral data
cubes, and successfully detected spectral tissue differences with sensitivity of 85.45%,
and specificity of 94.64% with true negative rate of 95.8%, and false positive rate of
4.2%. These results were verified by ground-truth marking of the tissue samples by
a pathologist. In the hyperspectral image analysis, the image processing algorithm,
K-means, shows the greatest potential for building a semi-automated system that could
identify and sort between normal and ductal carcinoma in situ tissues.
Keywords: hyperspectral, breast cancer, ductal carcinoma, spectral reflectance, hematoxylin and eosin,
unstained, K-means

INTRODUCTION
Breast cancer is one of the highest causes of cancer deaths among American women (1–4). According
to the U.S. Breast Cancer Organization, statistics show that about one in eight U.S. women will develop
invasive breast cancer over their lifetime (1–3). In 2016, about 246,660 new cases of invasive breast
cancer were diagnosed in women. The role of the pathologist is undeniably important for cancer
diagnosis (4, 5). However, as the number of breast cancer cases increases, the burden of pathological
cases becomes onerous. Thus, any new technology that can expedite breast cancer detection and
diagnosis using biopsy slides, making the process easier and more efficient, is warranted.
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Hyperspectral imaging (HSI) is a sophisticated non-invasive
optical imaging modality that has the potential to accelerate
medical imaging research and clinical practice. It is an optical
imaging modality that collects and analyzes spectral information
from across the electromagnetic spectrum, typically spanning the
visible wavelengths between 450 and 700 nm, but also extending
to the infrared (>700 nm) and UV (<450 nm). HSI has advantages
over conventional imaging in that it provides the spectral reflection or absorption characteristics of the object being imaged in
the form of spectral channels contained in an image data hypercube (6–8). Preliminary research performed by the WVU Optical
Imaging group at the WVU Cancer Institute has demonstrated
that HSI and classification methods could distinguish between
tumor and normal tissue in animal experiments with different
tumor sizes without the use of contrast agents (9). The same
researchers imaged pathological slides using a hyperspectral
camera and reported the detection of head and neck metastasis
ex vivo with promising sensitivity and specificity.
The purpose of this study was to evaluate the performance
of a snapshot hyperspectral imager, the Arrow system from
Rebellion Photonics, to determine if measurable differences
in spectral properties exist between normal and various stages
of cancerous breast tissues fixed on biopsy slides (10, 11). We
hypothesized that a hyperspectral imager could spectrally determine the difference between normal and cancerous tissue on both
stained and unstained slides. In tissues verified by a pathologist,
we further predicted that image processing techniques could
successfully differentiate between tissues in a semi-automated
fashion (9, 12–14).

MATERIALS AND METHODS

Figure 1 | Hyperspectral cube (top). Pixel spectrum in the spectral
dimension (bottom).

Instrumentation
The hyperspectral camera was connected to an upright microscope (Nikon Optiphot-2) with at 12V-100W LL halogen lamp
illumination source to capture images from biopsy slides. All
images were captured using a CF Achromatic P40x objective. The
arrow snapshot HSI camera is capable of two imaging configurations with two different sets of spectral bands. The configuration
that was used in this study is 443 × 313 pixel resolution in the
spatial domain, with 31 bands in spectral domain. The spectral
range of this system is within the visible light spectrum between
461 and 641 nm. The field of view of the hyperspectral camera
attached to the microscope with a 40× objective in its best resolution is 100 µm × 80 µm, allowing the capture of many images
from a single tissue sample, which averaged 8.0 × 10−5 cm2 for
this study.
An illustration showing the hyperspectral cube and graph of
pixel spectrum are shown in Figure 1. The hypercube is essentially
a three-dimensional dataset, which means even a single pixel contains a feature vector with over 10 dimensions within the entire
spectrum of reflectance information (15, 16). The technology of
the hyperspectral imager requires using optical sensors, which are
adjusted to collect spectral information in several narrow bands
or channels. Typically, these channels range between 2 and 10 nm
wide. HSI sensors produce image data in dozens or hundreds of
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narrow spectral bands (17–21). HSI technology, when properly
exploited, can be used in optical imaging applications such as
optical medical imaging in clinical and research applications
such as the work described here focused on breast cancer tissue
detection (22, 23).
The information collected from the imaging system was
analyzed to obtain a continuous spectrum for each image pixel
or cell as shown in Figure 2. Areas targeted by the imaging
system may have different biological, and chemical compositions
that can be detected by the sensor due to differences in light
reflection or absorption. The image spectra can be compared
with reflectance spectra collected in the field or in a laboratory
to recognize and map surface materials such as particular types
of vegetation or diagnostic minerals associated with ore deposits
(20). Hyperspectral images contain a rich collection of data, which
requires an understanding of the optical properties of different
materials, how they are being measured, and how they relate to
the measurements made by the hyperspectral sensor (20).
There are several methods used to create hyperspectral
imagery. When comparing between different methods, such as
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Figure 2 | Regular image of the breast tissue, hyperspectral image, and the spectrum of the marked pixel.

Figure 3 | Building the spectral data cube in both line scan and snapshot systems.

hyperspectral line scan and hyperspectral snapshot imaging,
it is important to consider both imaging techniques, as well as
advantages and disadvantages of both systems (24, 25). In the case
of line scan, each image collects one wavelength after the other,
and the field of view of the imaging system is fixed to build the
hypercube (26, 27). However, in the case of the snapshot method,
both spatial and spectral information of the target are captured
with one exposure (28).

Frontiers in Oncology | www.frontiersin.org

The snapshot method (used in this study) is an imaging
technique that does not require scanning at all. As shown in
Figure 3, the snapshot camera has the capability to produce a
complete spectral data cube in a single integration by directly
imaging the target zones onto the spectral, and spatial detectors simultaneously (28–30). In the line scan method, time
and stability are required, and it is necessary to wait until all
wavelength images have been recorded, which takes between

3

February 2018 | Volume 8 | Article 17

Khouj et al.

HSI for Histologic Evaluation of DCIS

several seconds to minutes of measurement time, in addition
to a few seconds wait time between scans, depending on the
imaged target and the imager capability from illumination and
integration conditions (31).

grouped as follows: (1) hematoxylin and eosin (H&E) stained
normal and ductal carcinoma in situ (DCIS) samples and (2)
unstained samples of normal and DCIS tissues. In the first imaging experiment, the HSI system was applied on 10 samples from
patients that have tested positive for invasive ductal carcinoma
breast cancer. Each patient has two H&E tissue samples marked
by a pathologist. The second imaging experiment includes set
of breast tissue samples taken from the same 10 patients, but
without staining to observe the spectral signature of both normal
and cancer tissues in an unstained state. The thickness of each
sample was 5 μm. Example images from biopsy slides shown in
Figure 4 for a single subject displaying both normal and DCIS
tissue DCIS. Each slide was imaged by the hyperspectral imager.
Figure 4 shows the H&E stained and unstained samples of the
normal ducts, and DCIS of the patient with a monochromatic
hyperspectral image at the chosen wavelength channel. A visible
image of H&E-stained as well as -unstained normal duct, and
DCIS tissue are shown for the example subject, as well as the
regions that were selected for HSI for select wavelengths ranging
from 460 to 650 nm.

HSI Image Processing and Data Analysis
Image processing consists of a mathematical algorithm that,
when applied, derives information from an image that can be
used in automated image analysis systems. K-means is a learning
algorithm used to solve unsupervised data classification problems
(15, 32). Unsupervised clustering is used to describe processes
where a classifier is assigned a dataset without preexisting labels
(33, 34). For hyperspectral data, the classifier can be used to find
spectral classes in a multiband image without assigned values
from the data provider. The clustering treats unsupervised data
by providing access to the tools to learn the classification from
the data itself to create clusters that group the data based on the
desired classification (34).
The idea is to define k centers, one for each cluster. Ideally, the
best choice is to place them as far away from each other as possible, to increase the detection accuracy, and to reduce the number
of error events (35). The next step is to take each point belonging
to a given data set and associate it to the nearest center. In this
case, each class will have one centroid, and the result becomes
more stable with increased iterations, which means they reach a
consensus. Also, the more data the classifier is given, the better
the centroid accuracy will be (35, 36).
Equations 1 and 2 describe the basic process of choosing clusters in the K-means algorithm. First, this algorithm minimizes
the objective function, J(V), is calculated using [Ref. (36)]:
J (V ) = ∑ i =1 ∑ i =1 ( xi − vi )
C

C

2

(1)

where “||xi − vj||” is the Euclidean distance between xi and vj. “ci”
is the number of data points in ith cluster, and “c” is the number
of cluster centers.
The process starts by randomly selecting “c” cluster centers,
then calculating the distance between each data point and cluster
centers. After that, a data point is assigned to the cluster center
whose distance from the cluster center is the minimum of all the
cluster centers.
The new cluster center, vi, is recalculated using the minimumdistance classifier equation [Ref. (35)]:
 1  ci
vi =   ∑ j =1 xi.
 ci 

(2)

Then, the distance between each data point and newly obtained
cluster centers is recalculated. Finally, if no data point was reassigned, the calculation loop is stopped. Otherwise, it is repeated
until no changes in the centroid values occur (35).

Cellular Imaging
This section provides a description of the snapshot HSI of
human breast cancer tissue [obtained under WVU IRB protocol
#1509816662 (Non-Human Subject Research)]. The samples are
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Figure 4 | Images of stained and unstained samples. The marked
[hyperspectral imaging (HSI)] are representing the chosen wavelength
channel (550 nm) for detection.
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RESULTS AND DISCUSSION

normal duct and in high density areas of the ductal carcinoma
samples known to contain tumorous tissue. The results of hyperspectral images from each patient will consist of a comparison
of spectral reflectance measurements from each area, and the
average with error and SD computed for 10 measurements from
each of 4 separate regions per ample type. Spectral reflectance
plots of the 4 marked areas of the stained tissue samples of 1 out
of 10 patients are shown in Figure 6.

The large amount of data contained in the three-dimensional
hyperspectral data cube was evaluated in multiple steps as shown
in Figure 5. All images were manually marked by a pathologist for
providing ground-truth description of the tissue samples showing
evidence of cancer. Training the auto detection algorithm and
evaluating the accuracy on tissue samples that are not included
in the training set is an important step. All marked areas on the
samples possessed a high density of tumor tissue within the designated region, as identified by the pathologist. Image processing
techniques were applied to look at the regions of interest identified
by the pathologist and, ultimately, determine the spectral reflectance of tissues in these regions over the visible light wavelength
spectrum. The image processing and HSI toolboxes contained
in both MATLAB and Waikato Environment for Knowledge
Analysis (WEKA) were used in image processing. WEKA is a
collection of machine learning algorithms for data mining tasks
that were developed at University of Waikato, New Zealand. In
this work, the algorithms are used to learn the about the nature of
the hyperspectral data to understand the spectral reflectance value
and how it can be used to differentiate between different regions
in the tissue samples. We analyzed the manually picked regions
of the hyperspectral images, then plotted the spectral reflectance
spectrum to compare between the tissues. A semi-automated
algorithm was applied to both the supervised, and unsupervised
(i.e., labeled, and unlabeled) hyperspectral data sets.

Unsupervised Data for K-Means Algorithm
on Human—Female H&E-Stained Breast
Tissue
The method used to process and analyze images were contained
in the HSI toolboxes of MATLAB and WEKA, as described
previously. The K-means algorithm was applied to unsupervised (i.e., unlabeled) data. The user chooses the number of
classes, which is 2 for this study (cancer, and non-cancer), and
then the algorithm picks the best centroid for each class. The
class centroids changes each time the algorithm runs until the
program stops, i.e., when the numbers of each class do not
change, and each centroid is considered the best pick. The table
in Figure 6 shows the results of applying K-means separately
on each set of data from 9 out of 10 patients for training,
iterating to find the two best values of centroids, and finally,
using the known labels of cancer and non-cancer to measure
the accuracy of each run. The last step is to run the K-means
trained algorithm on the 10th patient for testing the cancer
detection scheme to determine if the classifier can identify and
detect both classes, and then compare the detected results with
the ground-truth pathologist diagnosis in order to support the
algorithm accuracy.

Spectral Reflectance Determination of
Manually Marked Cancer Tissue
Because ductal carcinoma normally starts spreading from the
duct, four square regions were randomly picked around each

Figure 5 | Hyperspectral imaging, training, and semi-auto detection workflow.
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Figure 6 | Average response showing spectral reflectance of the cancer and normal tissues (A). The error bars quantify uncertainty in the graph based on an
average of 10 measurements taken from each of the four marked region of interest for both normal and cancer tissue (B). A clear separation between both tissues
was displayed at 550 nm. The table shows the results of applying K-means separately on each set of data from 9 to 10 subjects for training.

true-negative rate (TNR) of 95.8%, and a false-positive rate (FPR)
of 4.2%. The result of training the K-means algorithm on the data
that were extracted from the first 9 patients, then the trained algorithm was applied on the untrained data that were extracted from
the 10th patient. The algorithm successfully detected normal and
cancer tissue as shown in Figure 7. In this figure, the blue boxes
indicate the areas containing cancer marked by the pathologist,
and the red and blue shaded regions are the regions with cancer
identified by the hyperspectral detection algorithm.

CONCLUSION
The goal of this study is to evaluate the performance of a snapshot
hyperspectral imager to see if measurable differences in spectral
properties can be observed between normal and various stages of
cancerous breast tissues fixed on biopsy slides, specifically in the
case of ductal carcinoma. This interdisciplinary work may also
build a bridge between pathology and hyperspectral optical diagnostic imaging to reduce time and workload on the pathologist,
with a secondary benefit of leading to more accurate diagnoses.
Hyperspectral imaging technology was used to image stained
and unstained tissue samples of normal and DCIS tissue from
breast cancer patients. A region of interest in each tissue sample

Figure 7 | The blue boxes indicates the areas marked by the pathologist,
the shaded areas shows the detection of the K-means algorithm detecting
cancer tissues (red), and normal tissues (blue) on the spectral channel
550 nm.

K-means algorithm was applied to the hyperspectral data
cubes, and we successfully detected spectral tissue differences
with sensitivity of 85.45%, and specificity of 94.64% with a
Frontiers in Oncology | www.frontiersin.org
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was manually chosen for testing to evaluate the effectiveness
of automated cancer detection in these samples. The imaging
results showed clear spectral reflectance separation between
stained normal and ductal carcinoma tissues, with a TNR of
95.8%, and a FPR of 4.2%. These results indicate that the algorithm could provide a semi-automated “first pass” analysis of
histology slides and flag those of interest or concern for further
review by a pathologist. In most cases, the results showed the
largest separation at the 550-nm wavelength channel of the
snapshot hyperspectral camera, making it a good wavelength to
choose as starting reference for testing the spectral reflectance
of new samples. In the hyperspectral image analysis, the image
processing algorithm, K-means, showed the greatest potential
of building a semi-automated system that can identify and sort
between the samples with a high degree of difference in spectral
reflectance. This technique may also be used to distinguish
between cancer cells at various stages of progression, as well
as to develop a more advanced algorithm to allow a user to
distinguish tumor margins from normal and cancerous tissue.

Using a HSI system with the development of trained algorithms
for detection shows great potential in automating cancer diagnostics in the future.
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